Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma. Nguyen VTM, Namba H, Porter H, Shlyueva D, et al. Blood 2025 Feb 26:blood.2024026534. doi: 10.1182/blood.2024026534.

Read + Share

Amedeo Smart

Independent Medical Education

Nguyen VTM, Namba H, Porter H, Shlyueva D, et al. Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma. Blood 2025 Feb 26:blood.2024026534. doi: 10.1182/blood.2024026534.
PMID: 40009485